• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble

Laronde

Ship sailing through stormy seas
Biotech

Flagship's Sail Biomedicines lays off 12 staffers

The cuts leave 125 staff still employed at the programmable medicines company, which formed from a 2023 merger of Laronde and Senda Biosciences.
Darren Incorvaia Apr 1, 2025 3:44pm
parachute chutes and ladders

Google DeepMind vet to join GSK—Chutes & Ladders

Oct 20, 2023 9:30am
sailboat ocean sea water boat ship

Flagship's embattled Laronde sets sail with Senda in merger

Oct 19, 2023 1:51pm
venture capital funding

Biotech's top 10 money raisers of 2021

Apr 18, 2022 3:00am
Diego Miralles MD CEO of Laronde and CEO-partner at Flagship Pioneering

Laronde banks $440M to ramp up next-gen RNA-based meds

Aug 30, 2021 6:30am
Flagship Pioneering office

Flagship debuts Laronde to turn cells into drug factories

May 10, 2021 6:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings